PeptidePicker
Get Started
Home/Peptides/Tirzepatide
Weight LossFDA Approved

Tirzepatide

Also known as: Mounjaro · Zepbound · LY3298176

A dual GIP/GLP-1 receptor agonist delivering up to 22% weight loss in clinical trials. FDA-approved as Mounjaro and Zepbound, it outperforms single-pathway GLP-1 drugs.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~5 days

Typical Dose

10–15 mg weekly

Administration

Subcutaneous injection

Mechanism of Action

Simultaneously activates GIP and GLP-1 receptors to enhance insulin secretion, improve insulin sensitivity, reduce appetite, and promote fat oxidation.

Key Research Areas

weight lossdiabetesGLP-1GIPFDA approved

Frequently Asked Questions

What is Tirzepatide?▾
A dual GIP/GLP-1 receptor agonist delivering up to 22% weight loss in clinical trials. FDA-approved as Mounjaro and Zepbound, it outperforms single-pathway GLP-1 drugs.
How does Tirzepatide work?▾
Simultaneously activates GIP and GLP-1 receptors to enhance insulin secretion, improve insulin sensitivity, reduce appetite, and promote fat oxidation.
What is the recommended dosage for Tirzepatide?▾
The typical research dosage is 10–15 mg weekly, administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Tirzepatide?▾
The half-life of Tirzepatide is approximately ~5 days. This affects dosing frequency and timing in research protocols.
Is Tirzepatide FDA approved?▾
Yes, Tirzepatide is FDA approved for specific medical indications. Consult your physician for proper medical guidance.

Research Disclaimer

The information provided about Tirzepatide is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Weight Loss

Semaglutide

Ozempic · Wegovy

Retatrutide

LY3437943 · Triple G agonist

Liraglutide

Victoza · Saxenda

Dulaglutide

Trulicity · LY2189265

Back to All PeptidesFind Your Peptide — Take the Quiz